A rapid immunoassay for simultaneous detection and differential diagnosis of SARS-CoV-2, influenza type A, and type B antigens from nasal and nasopharyngeal swab specimens. Provides results in 15 minutes with FDA 510(k) clearance and CLIA waiver status.
Manufactured by
United States
LifeSign/PBM is a medical diagnostics company delivering rapid point of care testing products to the clinical laboratory. Their products are used worldwide for the detection of infectious disease, women's health, drugs of abuse and cardiac markers. Products are developed and manufactured under ISO, cGMP and CE guidelines and supported with quality standards by their team of sales, technical and customer service professionals.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Famwell
United States · 2 relevant products
ProGnosis Biotech S.A.
Greece · 2 relevant products
Advin Biotech, Inc.
United States · 1 relevant product
75 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 117 closest product alternatives
Famwell · United States
FDA 510(k) cleared and CLIA waived cassette-format test for rapid detection of influenza A and B antigens from nasopharyngeal swabs. Provides results within 10 minutes with 85.7% positive predictive accuracy and high negative predictive accuracy. Packaged in boxes of 25 tests with 18-month shelf life.
ProGnosis Biotech S.A. · Greece
Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
Advin Biotech, Inc. · United States
Multiplex rapid test simultaneously detecting COVID-19, influenza A, and influenza B from a single specimen. FDA cleared with results available in 5 minutes.
114 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products